Search
MIV-701
go.drugbank.com/drugs/DB05736ExperimentalMIV-701 is a selective, potent inhibitor of the protease Cathepsin K. It is developed for the treatment of osteoporosis.
Benzoxonium
go.drugbank.com/drugs/DB13565ExperimentalCategories: Alimentary Tract and Metabolism, Antiseptics and DisinfectantsChlormadinone
go.drugbank.com/drugs/DB13528InvestigationalCategories: chlormadinone and estrogen, chlormadinone and ethinylestradiolPafuramidine
go.drugbank.com/drugs/DB06532InvestigationalPafuramidine, a prodrug of furamidine, currently has orphan status for Pneumocystis jiroveci pneumonia.
Zinc picolinate
go.drugbank.com/drugs/DB11175InvestigationalIt is available as OTC dietary supplements as a source of zinc to treat and prevent zinc deficiency. The absorption of zinc after oral administration of zinc picolinate is shown to be effective.
Efinopegdutide
go.drugbank.com/drugs/DB15077InvestigationalNCT03606057 (A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and
Giredestrant
go.drugbank.com/drugs/DB19125InvestigationalGiredestrant is under investigation in clinical trial NCT06065748 (A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With Er-positive
Bevurogant
go.drugbank.com/drugs/DB21507ExperimentalThe usage of the INN stem '-rogant' in the name indicates that Bevurogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.
Izumerogant
go.drugbank.com/drugs/DB21604ExperimentalThe usage of the INN stem '-rogant' in the name indicates that Izumerogant is a retinoic acid receptor-related orphan receptor gamma (RORY) antagonist and inverse agonist.